Journal articleMol Cancer Res2021
AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with PARG Inhibition.
- Journal
- Mol Cancer Res
- Published
- 16 February 2021
- Citations
- 20
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 4
- Gastrointestinal Cancer P30CA056036↗
- Community Outreach and Engagement P30CA069533↗
- Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer R01CA212600↗
- Comparative analysis between patient-derived models of pancreatic ductal adenocarcinomas and matched tumor specimens U01CA224012↗